Morgan Stanley Maintains Overweight on iRhythm Technologies, Lowers Price Target to $128

Benzinga · 01/06/2023 14:47
Morgan Stanley analyst Cecilia Furlong maintains iRhythm Technologies (NASDAQ:IRTC) with a Overweight and lowers the price target from $165 to $128.